Table 2.
Parameters | Univerlate analysis | Multivariate analysis | ||
---|---|---|---|---|
| ||||
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | |
Age (years) | ||||
< 45 vs ≥ 45 | 5.458 (0.989-30.125) | 0.052 | ||
Gender | ||||
Male vs Female | 1.242 (0.328-4.710) | 0.75 | ||
Type of surgery | ||||
Right resection vs Left and total resection | 1.669 (0.638-4.365) | 0.296 | ||
Tumor size (mm) | ||||
< 10 vs ≥ 10 | 0.970 (0.269-3.504) | 0.963 | ||
Tumor focus | ||||
Unifocal vs Multifocal | 0.506 (0.096-2.658) | 0.421 | ||
Lymph node metastasis | ||||
Yes vs No | 0.343 (0.041-2.868) | 0.323 | ||
Pathological TNM classification | ||||
T stage | ||||
T1 vs T2+T3 | 1.271 (0.211-7.660) | 0.793 | ||
N stage | ||||
N0 vs N1a+N1b | 0.548 (0.117-2.572) | 0.446 | ||
TNM stage | ||||
I+II vs III+VIa | 0.533 (0.292-0.972) | 0.04 | 0.503 (0.266-0.951) | 0.035 |
White blood cell (W) | ||||
< 5.82 vs ≥ 5.82 | 0.155 (0.022-1.087) | 0.061 | ||
Hemoglobin (Hb) | ||||
< 137 vs ≥ 137 | 0.979 (0.247-3.885) | 0.976 | ||
Neutrophils (N) | ||||
< 3.30 vs ≥ 3.30 | 6.646 (0.790-55.880) | 0.081 | ||
Monocyte (M) | ||||
< 0.30 vs ≥ 0.30 | 3.426 (1.158-10.135) | 0.026 | 4.056 (1.268-12.973) | 0.018 |
Platelet (P) | ||||
< 221 vs ≥ 221 | 2.028 (0.559-7.354) | 0.282 | ||
Lymphocyte (L) | ||||
< 1.90 vs ≥ 1.90 | 1.991 (0.482-8.226) | 0.341 | ||
SIRI | ||||
< 0.43 vs ≥ 0.43 | 2.206 (0.884-5.503) | 0.033 | 2.574 (1.005-6.590) | 0.049 |
Ki-67 | ||||
Positive vs Negative | 0.588 (0.143-2.425) | 0.463 | ||
P53 | ||||
Positive vs Negative | 0.598 (0.182-1.967) | 0.398 | ||
CK19 | ||||
Positive vs Negative | 1.742 (0.467-6.494) | 0.408 | ||
Galectin-3 | ||||
Positive vs Negative | 4.583 (1.294-16.233) | 0.018 | 7.116 (1.598-31.699) | 0.010 |
CD56 | ||||
Positive vs Negative | 0.624 (0.156-2.497) | 0.505 |